Fain Eric S

SEC Form 4 insider trading activity

Fain Eric S has filed 3 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Aug 14, 2026.

On the most recent filing, Fain Eric S is listed as Director at Orchestra BioMed Holdings, Inc. Inside the rolling window, Fain Eric S reported 1 open-market purchase totaling $83K in OBIO and no open-market sales.

Companies traded

Other insiders at OBIO

Insider Buying

$83K

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Companies

1

in the rolling window

Source
OBIO
Fain Eric S
Purchase$83KMay 18SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Fain Eric S made?

Fain Eric S has filed 3 SEC Form 4 filings (4 transaction rows) across 1 company since 2026.

Which companies does Fain Eric S trade?

Fain Eric S has filed SEC Form 4 disclosures for 1 company, including OBIO.

When was Fain Eric S's most recent SEC Form 4 filing?

Fain Eric S's most recent SEC Form 4 filing on Tracefour is dated Aug 14, 2026.

What is Fain Eric S's total buy and sell value in the current window?

Inside the rolling retention window, Fain Eric S bought $83K and sold $0 based on SEC Form 4 filings.

What was Fain Eric S's largest disclosed transaction?

The largest disclosed transaction in the current window is a purchase of 20,000 OBIO shares on 2026-05-14, worth $83K, per SEC Form 4 filings.